Position in MGNX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,752,525
+$1,024,817 QoQ
Shares Held
379,335
+50.6% QoQ
Ownership
0.596%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 68%
Shared 16%
None 16%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. MGNX ranks #142 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in MGNX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,752,525 | 379,335 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $727,708 | 251,803 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $302,316 | 187,775 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $580,576 | 345,582 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $615,650 | 508,803 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $819,942 | 645,625 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,331,185 | 717,288 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,903,949 | 882,660 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,818,610 | 898,497 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $15,474,530 | 1,051,259 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $11,687,335 | 1,214,900 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $5,690,999 | 1,221,245 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $6,630,332 | 1,239,315 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $7,645,390 | 1,066,303 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,071,576 | 755,824 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,626,519 | 470,093 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,701,885 | 915,894 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $10,222,701 | 1,160,352 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $19,835,809 | 1,235,876 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $25,485,738 | 1,217,084 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $34,335,245 | 1,278,304 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $35,424,621 | 1,112,233 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $28,000,025 | 1,224,848 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $34,278,174 | 1,360,785 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $38,175,741 | 1,367,326 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $7,907,022 | 1,358,595 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||